Bill Text: NY K00798 | 2019-2020 | General Assembly | Introduced


Bill Title: Memorializing Governor Andrew M. Cuomo to proclaim February 29, 2020, as Rare Disease Day in the State of New York

Spectrum: Slight Partisan Bill (Democrat 41-23)

Status: (Passed) 2020-02-27 - adopted [K00798 Detail]

Download: New_York-2019-K00798-Introduced.html

Assembly Resolution No. 798

BY: M. of A. McDonald

        MEMORIALIZING Governor Andrew M. Cuomo to proclaim
        February  29, 2020, as Rare Disease Awareness Day in
        the State of New York

  WHEREAS, It is the custom of  this  Legislative  Body  to  recognize
official  days  set  aside  to increase awareness of serious issues that
affect the lives of citizens of New York State; and

  WHEREAS, Attendant to such concern, and  in  full  accord  with  its
long-standing  traditions,  it  is the sense of this Legislative Body to
memorialize Governor Andrew M. Cuomo to proclaim February 29,  2020,  as
Rare Disease Awareness Day in the State of New York, in conjunction with
the observance of National Rare Disease Day; and

  WHEREAS,  National  Rare  Disease  Day  is  an  observance  to raise
awareness of rare diseases and diseases of unmet need, few of which have
cures or specific drugs to treat symptoms, and are often  not  diagnosed
for many years; and

  WHEREAS,  The  first  Rare  Disease Day was held in 2008 on February
29th, a 'rare' date which happens only once every four years; ever since
then, Rare Disease Day has taken place on the last day  of  February,  a
month known for having a 'rare' number of days; and

  WHEREAS,  Rare Disease Day was established for the reason, according
to  the  European  Organization  for  Rare  Diseases  (EURORDIS),   that
treatment  for  many  rare  diseases  and  diseases  of  unmet  need  is
insufficient, as are the social networks  to  support  individuals  with
rare diseases and diseases of unmet need and their families; and

  WHEREAS,  One  year  later, in 2009, Rare Disease Day went global as
the National Organization of Rare Disorders (NORD)  mobilized  200  rare
disease patient advocacy organizations in the United States in an effort
to coordinate activities and better promote the day; and

  WHEREAS,  2020 marks the 12th Anniversary of Rare Disease Day in the
United States; this year's theme is: "Reframe Rare"; When the  challenge
of  raising  awareness for people affected by a rare disease still looms
on  Rare  Disease  Day  we  must  re-double   our   efforts,   re-think,
re-envision,  re-imagine,  reframe  what it means to be 'rare'; in fact,
rare is not scarce, rare is not infrequent, rare is not remote; we  need
society to understand that millions of people living with a rare disease
face inequitable access to diagnosis, treatment and care; and

  WHEREAS,  In 2013, in recognition of the needs of patients with rare
diseases, Albany Medical  Center  and  College  established  the  Albany
Medical  Center's  Rare  Disease Forum, which was the genesis of the New
York State Rare Disease Alliance, whose purpose  is  to  promote  faster
diagnosis  of  rare  diseases, research into therapies and cures, and to
foster wider public recognition of public health problems  affecting  30
million Americans; and

  WHEREAS,  There  are nearly 7,000 diseases and conditions considered
rare, each year affecting  approximately  25-30  million  Americans  and
1-in-10 individuals in New York State has a known rare diseases; and

  WHEREAS, Of these 7,000 rare diseases, more than 90% are without FDA
approved treatment; and

  WHEREAS,  Since  many  rare  diseases and diseases of unmet need are
genetic, tragically, approximately half  the  people  affected  by  rare
diseases in the United States are children; and

  WHEREAS,  Research  on  rare  diseases,  which are serious and often
life-threatening,  is  vitally  important  due  to  it  frequently  adds
significantly  to  the general understanding of more common diseases and
conditions; and

  WHEREAS, People suffering from rare  diseases  typically  experience
difficulty in obtaining a timely, accurate diagnosis, finding physicians
or  treatment  centers and experience limited treatment options, options
generally considered more expensive than those for common diseases; and

  WHEREAS, Biopharmaceutical research companies, academic researchers,
patient groups, and others are applying the growing understanding of the
causes of rare diseases to speed the development of new  treatments  for
patients;  the  Orphan  Drug Act of 1983 has been and continues to be an
important force in driving treatment innovation for rare diseases; and

  WHEREAS, Advances in DNA sequencing have led to  the  identification
of the genetic cause of several rare disease, which can potentially lead
to  better  understanding  of  the  disease  and development of targeted
therapies; and

  WHEREAS, Today, there is more hope than ever before  with  over  560
medicines  in  development for patients with rare diseases; medicines in
development include 151 for rare cancers and 82 for rare blood  cancers,
accounting  for 40 percent of all rare disease medicines in development;
148 for genetic disorders, including cystic fibrosis and spinal muscular
atrophy; 38 for neurological disorders,  including  amyotrophic  lateral
sclerosis (ALS) and seizures; 31 for infectious diseases, including rare
bacterial   infections   and  hepatitis;  25  for  autoimmune  diseases,
including systemic sclerosis and juvenile arthritis; and

  WHEREAS, Currently, research has led to  powerful  new  gene-editing
techniques holding promise for cures for blood disorders (such as Sickle
Cell   Disease,   Thalassemia,  Hemophilia),  Cancer,  Blindness,  Aids,
Muscular Dystrophy, Cystic Fibrosis, and Huntington's disease; and

  WHEREAS, These treatment options and medicines in development attack
the root of the cause for these patients that had few  or  no  treatment
options before; and

  WHEREAS,  It is imperative that there be greater public awareness of
rare diseases and diseases of unmet need,  and  more  must  be  done  to
increase  activity  at  the  local, state and national levels to support
those  afflicted  as  well  as  their  families  and  caregivers;   now,
therefore, be it

  RESOLVED,  That  this Legislative Body pause in its deliberations to
memorialize Governor Andrew M. Cuomo to proclaim February 29,  2020,  as
Rare  Disease  Day  in  the  State  of New York, in conjunction with the
observance of National Rare Disease Day; and be it further

  RESOLVED,  That  copies  of  this Resolution, suitably engrossed, be
transmitted to The Honorable Andrew M. Cuomo, Governor of the  State  of
New York; the New York State Rare Disease Alliance; and NORD.
feedback